Who are Endo's investors?

Endo's investors include Signet Healthcare Partners.

How much funding has Endo raised?

Endo has disclosed $170.6M raised across 1 round.

Where is Endo headquartered?

Endo is headquartered in Malvern, US.

Endo

Malvern, US · Founded 2023 · Delaware corporation · 1 known investors

Keenova is a specialty therapeutics company focused on rare, stigmatized, or unaddressed conditions across areas including immunology, urology, hepatology, ophthalmology, orthopedics, and critical care. Par Health develops generic pharmaceuticals, sterile injectables, and active pharmaceutical ingredients with U.S.-based manufacturing capabilities.

Biotech Healthtech Medical Devices

Founders & leadership

Blaise ColemaninPresident; Chief Executive Officer

Matthew MalettainExecutive Vice President; Chief Legal Officer; Secretary

Frank RacitiinVice President; Controller; Chief Accounting Officer

Mark BradleyinExecutive Vice President; Chief Financial Officer

Scott HirschNamed on SEC filing

Paul EfronNamed on SEC filing

Paul HerendeenNamed on SEC filing

Marc YoskowitzNamed on SEC filing

Patrick BarryNamed on SEC filing

Sophia LangloisNamed on SEC filing

Andy PasternakNamed on SEC filing

Investors · 1

Signet Healthcare PartnersNew York · $10M – $50M

Reported raises · per SEC filings

Form D private placements

$170.6M disclosed across 1 round · 2024

▶$170.6MraisedMay 2024 · 404 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Scott HirschDirector
Paul EfronDirector
Paul HerendeenDirector
Marc YoskowitzDirector
Patrick BarryExecutive Officer
Blaise ColemanExecutive Officer, Director
Matthew MalettaExecutive Officer
Sophia LangloisDirector
Frank RacitiExecutive Officer
Mark BradleyExecutive Officer, Director
Andy PasternakDirector

Offering amount: $170.6M
Amount sold: $170.6M
First sale: Mar 2024
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Medscape48 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Companies competing with Endo for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Endo do?: Keenova is a specialty therapeutics company focused on rare, stigmatized, or unaddressed conditions across areas including immunology, urology, hepatology, ophthalmology, orthopedics, and critical care. Par Health develops generic pharmaceuticals, sterile injectables, and active pharmaceutical ingredients with U.S.-based manufacturing capabilities.
Who are Endo's investors?: Endo's investors include Signet Healthcare Partners.
How much funding has Endo raised?: Endo has disclosed $170.6M raised across 1 round.
Where is Endo headquartered?: Endo is headquartered in Malvern, US.